Progressive Attenuation of Myocardial Vascular Endothelial Growth Factor Expression Is a Seminal Event in Diabetic Cardiomyopathy: Restoration of Microvascular Homeostasis and Recovery of Cardiac Function in Diabetic Cardiomyopathy After Replenishment of Local Vascular Endothelial Growth Factor

Background—Diabetic cardiomyopathy (DCM) is characterized by microvascular pathology and interstitial fibrosis, which leads to progressive heart failure; however, the pathogenesis of DCM remains uncertain. Methods and Results—Using the streptozotocin-induced diabetic rat model, we evaluated the natural course of DCM over a period of 1 year by serial echocardiography, Western blot analysis for vascular endothelial growth factor (VEGF), endothelial progenitor cell assays, myocardial blood flow measurements, and histopathologic analysis that included terminal dUTP nick end-labeling (TUNEL), capillary and cardiomyocyte density, and fibrosis area. Downregulation of myocardial VEGF expression preceded all other features of DCM and was followed by increased apoptosis of endothelial cells, decreased numbers of circulating endothelial progenitor cells, decreased capillary density, and impaired myocardial perfusion. Apoptosis and necrosis of cardiomyocytes ensued, along with fibrosis and progressive diastolic and then systolic dysfunction. To provide further evidence of the central role of VEGF in the pathophysiology of DCM, we replenished myocardial VEGF expression using naked DNA gene therapy via direct intramyocardial injection of plasmid DNA encoding VEGF (phVEGF165). VEGF-replenished rats showed increased capillary density, decreased endothelial cell and cardiomyocyte apoptosis, and in situ differentiation of bone marrow–derived endothelial progenitor cells into endothelial cells. These anatomic findings were accompanied by significant improvements in cardiac function. Conclusions—These findings suggest that downregulation of VEGF may compromise microvascular homeostasis in the myocardium and thereby play a central role in the pathogenesis of DCM.

[1]  E. Van Obberghen,et al.  Insulin and Insulin-like Growth Factor-I Induce Vascular Endothelial Growth Factor mRNA Expression via Different Signaling Pathways* , 2000, The Journal of Biological Chemistry.

[2]  S. Ahmed,et al.  Evidence for cardiomyopathy in familial diabetes mellitus. , 1977, The Journal of clinical investigation.

[3]  J. Isner,et al.  Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. , 2000, Circulation research.

[4]  Janet Rossant,et al.  A Requirement for Flk1 in Primitive and Definitive Hematopoiesis and Vasculogenesis , 1997, Cell.

[5]  J. Isner,et al.  Constitutive Expression of phVEGF 165 After Intramuscular Gene Transfer Promotes Collateral Vessel Development in Patients With Critical Limb Ischemia Clinical Investigation and Reports , 1998 .

[6]  M A Tries,et al.  Stable labeled microspheres to measure perfusion: validation of a neutron activation assay technique. , 2001, American Journal of Physiology. Heart and Circulatory Physiology.

[7]  Y. Yoon,et al.  VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. , 2003, The Journal of clinical investigation.

[8]  J. Neaton,et al.  Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.

[9]  J. Isner,et al.  VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells , 1999, The EMBO journal.

[10]  L. Rydén,et al.  Diabetes mellitus and congestive heart failure. Further knowledge needed. , 1999, European heart journal.

[11]  L. Aiello,et al.  Decreased Cardiac Expression of Vascular Endothelial Growth Factor and Its Receptors in Insulin-Resistant and Diabetic States: A Possible Explanation for Impaired Collateral Formation in Cardiac Tissue , 2002, Circulation.

[12]  M. Lesch,et al.  Progression of heart failure: A role for interstitial fibrosis , 1995, Molecular and Cellular Biochemistry.

[13]  C. Cetrulo,et al.  Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: balance between growth and death signals. , 1997, Journal of molecular and cellular cardiology.

[14]  James B. Seward,et al.  The echo manual , 2006 .

[15]  K Walsh,et al.  Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. , 1998, Circulation.

[16]  H. Bunko,et al.  Clinical studies on diabetic myocardial disease using exercise testing with myocardial scintigraphy and endomyocardial biopsy , 1986, Clinical cardiology.

[17]  Willem Flameng,et al.  Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188 , 1999, Nature Medicine.

[18]  D. Bell,et al.  Diabetic cardiomyopathy. , 2003, Diabetes care.

[19]  T. Asahara,et al.  Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. , 2002, Experimental hematology.

[20]  W. Kannel,et al.  Role of diabetes in congestive heart failure: the Framingham study. , 1974, The American journal of cardiology.

[21]  S. Factor,et al.  Capillary microaneurysms in the human diabetic heart. , 1980, The New England journal of medicine.

[22]  E. Keshet,et al.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.

[23]  P. Kang,et al.  Apoptosis and heart failure: A critical review of the literature. , 2000, Circulation research.

[24]  Y. Yazaki,et al.  Vascular endothelial growth factor induces activation and subcellular translocation of focal adhesion kinase (p125FAK) in cultured rat cardiac myocytes. , 1999, Circulation research.

[25]  J. Isner,et al.  Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. , 1999, The American journal of pathology.

[26]  J. Isner,et al.  Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. , 1996, Circulation.

[27]  G. Beller.  Coronary heart disease in the first 30 years of the 21st century: challenges and opportunities: The 33rd Annual James B. Herrick Lecture of the Council on Clinical Cardiology of the American Heart Association. , 2001, Circulation.

[28]  J. Isner,et al.  Reversal of experimental diabetic neuropathy by VEGF gene transfer. , 2001, The Journal of clinical investigation.

[29]  Yusu Gu,et al.  A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Demetris,et al.  Multilineage hematopoietic reconstitution of supralethally irradiated rats by syngeneic whole organ transplantation. With oarticular reference to the liver. , 1996, Transplantation.

[31]  Y. Yoon,et al.  Intramyocardial Transplantation of Autologous Endothelial Progenitor Cells for Therapeutic Neovascularization of Myocardial Ischemia , 2003, Circulation.

[32]  C. Kahn,et al.  Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization. , 2003, The Journal of clinical investigation.

[33]  A. Maseri,et al.  Myocardial Cell Death in Human Diabetes , 2000, Circulation research.

[34]  S. Litwin,et al.  Abnormal cardiac function in the streptozotocin-diabetic rat. Changes in active and passive properties of the left ventricle. , 1990, The Journal of clinical investigation.

[35]  L. Ştefăneanu,et al.  The myocardial microangiopathy in human and experimental diabetes mellitus. (A microscopic, ultrastructural, morphometric and computer-assisted symbolic-logic analysis). , 1986, Endocrinologie.

[36]  J. Isner,et al.  Estrogen-Mediated, Endothelial Nitric Oxide Synthase–Dependent Mobilization of Bone Marrow–Derived Endothelial Progenitor Cells Contributes to Reendothelialization After Arterial Injury , 2003, Circulation.

[37]  M. Goldberg,et al.  Regulation of vascular endothelial growth factor in cardiac myocytes. , 1995, Circulation research.

[38]  S. Schaffer,et al.  Development of a cardiomyopathy in a model of noninsulin-dependent diabetes. , 1985, The American journal of physiology.

[39]  H. Crijns,et al.  Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy. , 2000, Journal of the American College of Cardiology.

[40]  Warszawski Uniwersytet Medyczny,et al.  Diabetes care , 2019, Health at a Glance.

[41]  H. Traxler,et al.  Selective Downregulation of VEGF-A165, VEGF-R1, and Decreased Capillary Density in Patients With Dilative but Not Ischemic Cardiomyopathy , 2000, Circulation research.

[42]  R. Califf,et al.  Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience. , 1996, Journal of the American College of Cardiology.

[43]  J. Bullas,et al.  Hemodynamic assessment. , 1985, Critical care nurse.

[44]  K. Ohmori,et al.  Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. , 2000, Circulation.

[45]  A. Grishman,et al.  New type of cardiomyopathy associated with diabetic glomerulosclerosis. , 1972, The American journal of cardiology.